SCHEMBL264599

SCHEMBL264599

CCOC(=S)SC(C)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
CYP2D6 P10635 1/20 0.50
HSD17B10 Q99714 2/20 0.34
LMNA P02545 1/20 0.34
HDAC3 O15379 2/20 0.34
HDAC4 P56524 2/20 0.34
HDAC1 Q13547 2/20 0.34
HDAC7 Q8WUI4 2/20 0.34
HDAC2 Q92769 2/20 0.34
HDAC10 Q969S8 2/20 0.34
HDAC11 Q96DB2 2/20 0.34
HDAC8 Q9BY41 2/20 0.34
HDAC6 Q9UBN7 2/20 0.34
HDAC9 Q9UKV0 2/20 0.34
HDAC5 Q9UQL6 2/20 0.34
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA9 Q16790 2/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL238094 0.86 ALDH1A1 (0.47) ALDH1A1CYP2D6HSD17B10LMNAHDAC3
SCHEMBL17212355 0.84 ALDH1A1 (0.46) ALDH1A1CYP2D6HSD17B10LMNAHDAC3
SCHEMBL10063796 0.82 ALDH1A1 (0.44) ALDH1A1CYP2D6HSD17B10LMNAHDAC3
SCHEMBL12308922 0.82 ALDH1A1 (0.44) ALDH1A1CYP2D6HSD17B10LMNAHDAC3
SCHEMBL866981 0.82 ALDH1A1 (0.44) ALDH1A1CYP2D6HSD17B10LMNAHDAC3
SCHEMBL280619 0.82 ALDH1A1 (0.44) ALDH1A1CYP2D6HSD17B10LMNAHDAC3
SCHEMBL13047819 0.79 ALDH1A1 (0.42) ALDH1A1CYP2D6HSD17B10LMNAHDAC3
SCHEMBL18113065 0.79 ALDH1A1 (0.39) ALDH1A1CYP2D6HSD17B10LMNAALOX15
SCHEMBL12087618 0.78 ALDH1A1 (0.41) ALDH1A1CYP2D6HSD17B10LMNAHDAC3
SCHEMBL12222648 0.78 ALDH1A1 (0.41) ALDH1A1CYP2D6CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120132003-A Dual-wavelength-emission responsive optical micelle and preparation method and application thereof 安徽工程大学 2025-06-13 CN claimed
CN-120132003-A Dual-wavelength-emission responsive optical micelle and preparation method and application thereof 安徽工程大学 2025-06-13 CN disclosed
CN-118922473-A Block copolymer, process for producing the same and composition thereof 巴斯夫欧洲公司 2024-11-08 CN disclosed
WO-2023072893-A1 USE OF HIGH MOLECULAR WEIGHT NARROW POLYDISPERSITY POLYMERS AS FLOCCULANTS OR VISCOSIFIERS BASF SE (DE) 2023-05-04 WO disclosed
WO-2023072893-A1 USE OF HIGH MOLECULAR WEIGHT NARROW POLYDISPERSITY POLYMERS AS FLOCCULANTS OR VISCOSIFIERS BASF SE (DE) 2023-05-04 WO disclosed
EP-3277736-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS Basell Poliolefine Italia S.r.l. (IT) 2018-02-07 EP disclosed
EP-2443485-B1 BIOMEDICAL DEVICES BAUSCH & LOMB (US) 2017-11-08 EP disclosed
EP-2443482-B1 BIOMEDICAL DEVICES, POLYMERIC MATERIALS AND CONTACT LENSES COMPRISING THE SAME. BAUSCH & LOMB (US) 2017-03-01 EP disclosed
EP-2443486-B1 BIOMEDICAL DEVICES BAUSCH & LOMB (US) 2017-03-01 EP disclosed
US-20160340463-A1 PROCESS FOR PREPARING A POLYMER NEWSOUTH INNOVATIONS PTY LIMITED (AU) 2016-11-24 US disclosed
US-20100317816-A1 Biomedical devices BAUSCH & LOMB INCORPORATED (US) 2010-12-16 US disclosed
US-20100317816-A1 Biomedical devices BAUSCH & LOMB INCORPORATED (US) 2010-12-16 US disclosed
US-20100317817-A1 Biomedical devices BAUSCH & LOMB INCORPORATED (US) 2010-12-16 US disclosed
US-20100317817-A1 Biomedical devices BAUSCH & LOMB INCORPORATED (US) 2010-12-16 US disclosed
US-20100105832-A1 PROCESS FOR PREPARING AQUEOUS POLYACRYLIC ACID SOLUTIONS BY MEANS OF CONTROLLED FREE-RADICAL POLYMERIZATION BASF SE (DE) 2010-04-29 US disclosed
US-20100105832-A1 PROCESS FOR PREPARING AQUEOUS POLYACRYLIC ACID SOLUTIONS BY MEANS OF CONTROLLED FREE-RADICAL POLYMERIZATION BASF SE (DE) 2010-04-29 US disclosed
US-20100047203-A1 Use of Block Copolymers Based on Vinyllactams and Vinyl Acetate as Solubilizers BASF SE (DE) 2010-02-25 US disclosed
US-7462676-B2 Method for the controlled radical polymerisation of acrylic acid and the salts thereof, polymers thus obtained and applications thereof COATEX S.A.S. (FR) 2008-12-09 US disclosed
US-20070106042-A1 METHOD FOR THE CONTROLLED RADICAL POLYMERISATION OF ACRYLIC ACID AND THE SALTS THEREOF, POLYMERS THUS OBTAINED AND APPLICATIONS THEREOF COATEX S.A.S. (FR) 2007-05-10 US disclosed
WO-2002077075-A1 METHOD FOR PRODUCING CONTROLLED-SHAPE COLLOIDAL PARTICLES WITH WATER-SOLUBLE BLOCK COPOLYMERS COMPRISING A HYDROPHOBIC BLOCK AND A HYDROPHILIC BLOCK RHODIA CHIMIE (FR) 2002-10-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100047203-A1 Use of Block Copolymers Based on Vinyllactams and Vinyl Acetate as Solubilizers VCL, MGAM, PBRM1 ALDH1A1 2275/4885CYP2D6 1958/4885HSD17B10 2164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.